Trade Summary

3 days ago, Bohlin Garen G, serving as Dir at Collegium Pharmaceutical, Inc (COLL), sold 8,700 shares at $37.18 per share, for a total transaction value of $323,491.00. Following this transaction, Bohlin Garen G now holds 62,259 shares of COLL.

This sale represents a 12.00% decrease in Bohlin Garen G's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 2 days after the trade was made.

Collegium Pharmaceutical, Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.